These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2889094)

  • 1. Quinolone/ureidopenicillin cross-resistance.
    Piddock LJ; Wijnands WJ; Wise R
    Lancet; 1987 Oct; 2(8564):907. PubMed ID: 2889094
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").
    Stratford BC
    Med J Aust; 1968 Nov; 2(20):890-5. PubMed ID: 4973410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 5. R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.
    Sykes RB; Richmond MH
    Lancet; 1971 Aug; 2(7720):342-4. PubMed ID: 4105047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the anti-Pseudomonas aeruginosa activity of ureidopenicillins and recent advances in their research].
    Li JT
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):332-5. PubMed ID: 2510980
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbenicillin in treatment of severe infections due to pseudomonas.
    Jordan MC; Standiford HC; Kirby WM
    J Infect Dis; 1970 Sep; 122():Suppl:S96+. PubMed ID: 4319045
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa-acquired resistance to imipenem-cilastatin: commentary on clinical implications of antibiotic resistance.
    Tidwell BH; Cleary JD
    Pharmacotherapy; 1993; 13(2):165; discussion 166. PubMed ID: 8469624
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections of the lower respiratory tract: treatment with amoxicillin.
    Burns MW; Devitt L
    J Infect Dis; 1974 Jun; 129(0):suppl:S194-7. PubMed ID: 4152135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa].
    Malfatti S; Pardini C; Silvi G
    G Mal Infett Parassit; 1971 Nov; 23(11):1063-8. PubMed ID: 5004853
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbenicillin: a clinical and laboratory evaluation.
    Marks MI; Eickhoff TC
    Ann Intern Med; 1970 Aug; 73(2):179-87. PubMed ID: 4989316
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug resistance of bacteria--the current status and future prospect. 5. Pseudomonas aeruginosa].
    Nishimura T; Takashima T
    Nihon Rinsho; 1984 Mar; 42(3):676-89. PubMed ID: 6433078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
    Duval J; Soussy CJ
    Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiply resistant Pseudomonas aeruginosa in the pediatric field].
    Tabuki K
    Nihon Rinsho; 1991 Oct; 49(10):2387-92. PubMed ID: 1660948
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and microbiologic studies of carbenicillin.
    Michaeli D; Weinstein L
    J Infect Dis; 1970 Sep; 122():Suppl:S90-5. PubMed ID: 4990026
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
    Cullmann W; Stieglitz M; Baars B; Opferkuch W
    Chemotherapy; 1985; 31(1):19-28. PubMed ID: 3156025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.